article thumbnail

Reuters Events: Pharma & Patient USA | October 15-16, 2024

Pharma Marketing Network

You must integrate and co-create from the outset, from clinical design to commercial execution to boost adherence, trial participation and create exceptional outcomes. YOU are the patient advocate in your company, so overturn tokenistic gestures into meaningful actions that prioritise patients over patents. This starts now.

article thumbnail

Global decentralized studies will become a standard clinical trial design approach

The Pharma Data

“These focus areas will materialize in study designs as hybrid decentralized approaches that support global programs,” Reites said. “In In 2021, technology-enabled clinical research with a more global focus will become a standard clinical design approach.”. Source link: [link].


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

9th PREDiCT: Tumor Models Cell Therapy Summit


Join over 28 world-class speakers to see how classic and next-gen tumor models can be leveraged to expand your mechanism of action understanding, model the complexities of the tumor microenvironment, and guide your clinical design. Download the full event guide here for more information on what you can look forward to.

In-Vivo 52
article thumbnail

NHS pilots virtual assistant for flu jab bookings


Adding vaccination information, a self-service eligibility check, and booking functionality to Ask NHS lets patients, protect themselves and loved ones, quickly get the information they need and make appointments without having to call their clinic.

Nurses 75
article thumbnail

Common Pitfalls in Preparing an IND Application


Using nonclinical data or manufacturing information that doesn’t adequately support the clinical protocol hurts the IND application. It’s critical to ensure all nonclinical data supports the clinical design and provides adequate justification of the desired labeling claims – including basic exposure data.

article thumbnail

How Can You Manage the Complexity of Early Phase Clinical Development?


Cohen says this new infrastructure has been unveiled at Fortrea’s Leeds location in the UK and expanded to a couple of US clinics to include new Current Good Manufacturing Practice (CGMP) pharmacies. These changes, particularly the shift to fully digital spaces, facilitate more efficient and precise management of complex trials.